Senior Director/VP of Medical Affairs

Click Therapeutics•New York, NY

7h•Hybrid

About The Position

As a Senior Director / Vice President of Access, Policy, and Commercial Operations, you will be the backbone of the commercial organization. You will design the financial architecture of the product, shape the external policy and regulatory environments to support PDTs, and ensure long term viability of the PDT category. The role reports to the Chief Commercial Officer and will work closely with senior counterparts in the Medical Office and Strategy Office. We are looking for someone with a strong background in Policy and Market Access Operations to also develop the Click playbook for Prescription Digital Therapeutic (PDT) launches across multiple therapeutic areas. If you have an entrepreneurial spirit, are success-oriented and have a strong record of launching regulated products and building teams, you may be the right candidate. This is an agile position within a rapidly growing pre-IPO company in a nascent and fast-growing space. The role will be based in our NYC office, includes great benefits, and is an excellent wealth-building/equity opportunity for the right individual. This position can be based out of Click’s headquarters located in Tribeca, NYC, at the center of one of the fastest-growing digital health communities or at our industrious office in Boston, MA. We have a hybrid working model that consists of at least 4 days in office each week.

Requirements

Advanced Degree Required: PharmD
15+ years of progressive leadership within the pharmaceutical, biotech, or medtech sectors, with a significant portion dedicated to Medical Affairs and HEOR
Prior experience as an MSL
Proven track record of leading medical launch readiness for first-in-class products or complex specialty therapeutics.
Ability to translate complex clinical data into a compelling narrative that shifts provider behavior and therapeutic paradigms.
Exceptional emotional intelligence and a track record of building and mentoring diverse, high-performing medical teams.
Mastery of scientific storytelling; the ability to present to a room of specialists one hour and a board of investors the next.

Nice To Haves

Knowledge of or experience with Digital Therapeutics and/or Prescription Digital Therapeutics is considered a plus
Experience in other commercial functions (Marketing, Sales Enablement)

Responsibilities

Serves as the scientific authority for CT-155, collaborating closely with the internal Medical Office to ensure clinical alignment
Architect and execute the overarching US Medical Affairs strategy, ensuring alignment between clinical goals and real-world provider needs.
Establish and maintain high-level relationships with National and Regional Key Opinion Leaders (KOLs) to garner insights and build advocacy for the PDT category.
Serve as the primary scientific spokesperson for the company at major congresses, advisory boards, and with healthcare system leadership.
Establish strategic alliances with advocacy groups and caregiver networks to validate PDTs as a standard of care within the schizophrenia ecosystem.
Build and lead a high-performing Field Medical team, establishing KPIs for scientific engagement, provider education, and territory management.
Develop robust Medical Information systems to provide timely, accurate, and balanced responses to unsolicited requests for information from HCPs.
Ensure all medical materials and field interactions adhere to the highest standards of compliance and regulatory guidelines.
Generates evidence (RWE/OLE) to prove clinical value and economic impact for Marketing and Access usage
Leverage Real World Evidence (RWE) and Open Label Extension (OLE) data to create Budget Impact Models (BIM) and Cost-Effectiveness Analyses (HEOR).
Design future studies to fill evidence gaps required by payers.
Partner with the Access team to develop the Global Value Dossier and clinical sections of AMCP dossiers, ensuring P&T committees understand the clinical necessity of the PDT.
Translate complex digital health data (usage metrics, engagement rates) into "clinician-friendly" insights that demonstrate patient improvement and behavior change.
Leads the scientific narrative, publication strategy, and podium presentations
Lead Medical Advisory Boards to stress-test our value proposition against the evolving standard of care.